iShares Neuroscience and Healthcare ETF Rating $26.17 +0.17 (+0.65%) (As of 11/21/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.80Holdings in IBRN have an aggregate rating of Moderate Buy based on 369 analyst ratings issued in the past year covering 41 companies (85.8% of the portfolio).IBRN Aggregate Price Target$26.17High Prediction$26.17Average Prediction$26.17Low Prediction$26.17Holdings in IBRN have an aggregate price target of $26.17 and a range of $26.17 to $26.17 covering 41 companies (85.8% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy25 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 41 IBRN Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.16%BHVNBiohaven$45.19-3.5%3.9286 of 5 stars3.07$63.42 40.3%144.66%PTCTPTC Therapeutics$42.89+2.2%2.5575 of 5 stars2.33$42.00 -2.1%15Analyst Downgrade3.91%XENEXenon Pharmaceuticals$39.97+1.6%3.5287 of 5 stars3.08$57.45 43.7%123.90%CPRXCatalyst Pharmaceuticals$21.12-0.1%4.7575 of 5 stars3.00$31.14 47.5%73.72%ITCIIntra-Cellular Therapies$85.45-0.2%4.4853 of 5 stars2.85$97.23 13.8%133.70%ARGXargenx$600.35+1.4%2.9774 of 5 stars2.91$630.42 5.0%23Analyst Forecast3.68%AXNXAxonics$70.983.2809 of 5 stars2.00$71.00 0.0%8News Coverage3.67%SRPTSarepta Therapeutics$110.50-0.3%4.9418 of 5 stars3.00$181.33 64.1%22Analyst Downgrade3.63%EWTXEdgewise Therapeutics$32.10+0.4%1.7332 of 5 stars3.00$38.40 19.6%53.55%LBPHLongboard Pharmaceuticals$59.78+0.0%1.7728 of 5 stars2.44$59.56 -0.4%9Positive News3.50%ALKSAlkermes$27.79-0.4%4.8261 of 5 stars2.58$35.42 27.4%12Positive News3.49%NBIXNeurocrine Biosciences$125.00+1.4%4.957 of 5 stars2.83$163.91 31.1%24Positive News3.48%SRRKScholar Rock$26.74-4.0%4.6026 of 5 stars3.14$34.00 27.2%73.36%DYNDyne Therapeutics$29.79-0.7%3.4156 of 5 stars3.00$51.40 72.5%103.26%BIIBBiogen$158.43+1.6%4.8689 of 5 stars2.54$257.20 62.3%28Analyst Forecast3.22%ACADACADIA Pharmaceuticals$16.18-0.6%3.6792 of 5 stars2.65$25.56 58.0%17Insider TradeAnalyst Revision3.18%SUPNSupernus Pharmaceuticals$35.82-0.8%2.5211 of 5 stars2.50$36.00 0.5%2Positive News2.19%IARTIntegra LifeSciences$23.00+0.3%2.84 of 5 stars1.75$24.00 4.3%8Positive NewsHigh Trading Volume2.08%PRAXPraxis Precision Medicines$73.36-0.4%1.9864 of 5 stars2.89$146.33 99.5%92.07%AVDLAvadel Pharmaceuticals$11.67+8.5%2.5579 of 5 stars3.00$24.43 109.4%72.00%SAVACassava Sciences$32.06+23.1%3.7398 of 5 stars3.00$111.50 247.8%2High Trading Volume1.26%PRTAProthena$14.44+0.3%1.673 of 5 stars2.71$61.86 328.4%7Analyst Downgrade1.15%CAPRCapricor Therapeutics$17.93-5.2%3.8356 of 5 stars3.00$34.50 92.4%61.10%ANNXAnnexon$5.22+1.2%2.7745 of 5 stars3.00$15.80 202.5%60.99%DNTHDianthus Therapeutics$20.27-2.4%1.5039 of 5 stars3.20$46.43 129.1%100.98%AXGNAxoGen$13.10+1.6%2.7019 of 5 stars3.00$15.00 14.5%40.88%NGNENeurogene$15.59+1.7%2.9119 of 5 stars3.11$60.83 290.2%9Analyst ForecastAnalyst RevisionHigh Trading Volume0.77%RAPPRapport Therapeutics$22.52+1.5%1.6783 of 5 stars3.00$35.00 55.4%30.77%AVXLAnavex Life Sciences$9.02+6.4%3.6195 of 5 stars3.50$40.00 343.5%2Upcoming Earnings0.72%ZVRAZevra Therapeutics$9.13+1.8%3.4874 of 5 stars3.13$21.00 130.0%8Analyst ForecastAnalyst Revision0.65%TRDAEntrada Therapeutics$18.05+0.7%2.5385 of 5 stars3.00$24.00 33.0%2Positive News0.64%ALECAlector$3.76+3.3%4.3906 of 5 stars3.00$20.67 449.6%4Positive News0.56%CLPTClearPoint Neuro$11.09+1.2%0.5301 of 5 stars3.00$11.33 2.2%30.56%TSHATaysha Gene Therapies$2.18+8.5%3.945 of 5 stars3.00$6.63 203.9%80.54%VYGRVoyager Therapeutics$5.43+1.3%4.6642 of 5 stars3.00$17.00 213.1%90.53%SGMOSangamo Therapeutics$1.97+1.0%2.1797 of 5 stars2.67$7.00 255.5%30.53%LRMRLarimar Therapeutics$6.13+0.8%3.6903 of 5 stars3.09$20.43 233.3%11Analyst Forecast0.45%VNDAVanda Pharmaceuticals$4.94+0.8%4.451 of 5 stars3.00$15.50 213.8%20.45%ABEOAbeona Therapeutics$5.82+1.2%3.6156 of 5 stars3.00$18.00 209.5%3Analyst Upgrade0.42%CTNMContineum Therapeutics$14.34+5.1%1.6392 of 5 stars3.20$29.25 104.0%50.39%AMLXAmylyx Pharmaceuticals$5.244.194 of 5 stars2.60$11.43 118.3%10 This page (NYSEARCA:IBRN) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
